Drūl
Developer of an in‑office saliva testing platform that performs same‑visit, chairside nucleic acid‑based detection and quantification of oral bacteria to support earlier diagnosis and treatment planning in dental practices. The company also builds a saliva biomarker discovery engine and AI‑driven analytics to expand saliva testing toward systemic disease detection.
Industries
Nr. of Employees
small (1-50)
Products
In‑office saliva testing device and reporting platform
A chairside device that processes saliva samples, performs nucleic acid‑based detection and quantification of oral bacteria, and delivers visual reports to clinicians and patients within a single appointment.
In‑office saliva testing device and reporting platform
A chairside device that processes saliva samples, performs nucleic acid‑based detection and quantification of oral bacteria, and delivers visual reports to clinicians and patients within a single appointment.
Services
Clinical pilot program for dental practices
Onboarding, training, and support for dental practices to deploy same‑visit saliva testing and integrate results into care pathways.
Saliva biomarker discovery collaboration
Partnerships with dentists and researchers to collect saliva samples and contribute to a biomarker discovery engine for oral and systemic disease research.
Clinical pilot program for dental practices
Onboarding, training, and support for dental practices to deploy same‑visit saliva testing and integrate results into care pathways.
Saliva biomarker discovery collaboration
Partnerships with dentists and researchers to collect saliva samples and contribute to a biomarker discovery engine for oral and systemic disease research.
Expertise Areas
- Saliva-based diagnostics
- Oral microbiome biomarker discovery
- Point-of-care diagnostic device development
- Microfluidics
Key Technologies
- Microfluidics
- Nucleic acid analysis (DNA-based detection)
- Machine learning and AI analytics
- Automation for sample processing